Results 71 to 80 of about 5,026 (202)

Preoperative Plasma Soluble Urokinase Plasminogen Activator Receptor as a Prognostic Marker in Rectal Cancer Patients. An Eortc-Receptor and Biomarker Group Collaboration

The International Journal of Biological Markers, 2005
Background and aims Since approximately 30% of patients with Dukes’ stage B colorectal cancer will experience disease recurrence within five years of primary treatment, current staging of patients with early colorectal cancer apparently fails to ...
R. Riisbro, I.J. Christensen, H.J. Nielsen, N. Brünner, M. Nilbert, E. Fernebro   +5 more
doaj   +1 more source

Self-rated health and chronic inflammation are related and independently associated with hospitalization and long-term mortality in the general population

Scientific Reports, 2022
The subjective indicator of health self-rated health (SRH) and the chronic inflammation biomarker soluble urokinase plasminogen activator receptor (suPAR) are both robust predictors of healthcare use and mortality.
Juliette Tavenier, Line Jee Hartmann Rasmussen, Janne Tolstrup, Janne Petersen, Jakob Sobocki, Charlotta Pisinger, Jesper Eugen-Olsen, Hejdi Gamst-Jensen   +7 more
doaj   +1 more source

Measurement of serum suPAR is not ready for clinical use [PDF]

Nature Reviews Nephrology, 2014
Item does not contain ...
Deegens, J.K., Wetzels, J.
openaire   +3 more sources

Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab

BMC Nephrology, 2018
Background Therapeutic plasma exchange (TPE) is an important therapy for recurrent focal segmental glomerulosclerosis (rFSGS) post kidney transplant. suPAR has been causally implicated in rFSGS, and shown to be a unique biomarker for the occurrence and ...
Nada Alachkar, Jing Li, Dany Matar, Vikas Vujjini, Sami Alasfar, Melissa Tracy, Jochen Reiser, Changli Wei   +7 more
doaj   +1 more source

Effect of remission induction therapy on the level of soluble urokinase plasminogen activator receptor in acute myeloid leukemia

Iraqi Journal of Hematology, 2020
BACKGROUND: Soluble urokinase plasminogen activator receptor (suPAR) in acute myeloid leukemia (AML) is associated with resistance to chemotherapy. The aim is to assess the effect of remission induction on plasma level of suPAR in AML patients and to ...
Eman Qassim Ahmed, Haithem Ahmed Al-Rubaie   +1 more
doaj   +1 more source

Association of Serum hs‐CRP and TNF‐α With Therapeutic Response to Erenumab for Migraine Prevention: A Registry for Migraine (REFORM) Study

European Journal of Neurology, Volume 33, Issue 7, July 2026.
In this prospective study of 623 adults with migraine treated with erenumab, baseline serum hs‐CRP and TNF‐α were not associated with treatment response. Serum TNF‐α increased modestly during treatment, but changes did not differ between responders and non‐responders.
William K. Karlsson, Rune H. Christensen, Haidar M. Al‐Khazali, Dorte A. Olsen, Jonna S. Madsen, Messoud Ashina, Håkan Ashina   +6 more
wiley   +1 more source

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis.

PLoS ONE, 2019
BackgroundThe soluble urokinase plasminogen activator receptor (suPAR) is related to hepatic inflammation and fibrosis and has been suggested to participate in the development of liver cirrhosis. Therefore, the aim of the current study was to measure the
Emilie Garnæs, Christian Mortensen, Lise Hobolth, Ove Andersen, Jan Nehlin, Søren Møller   +5 more
doaj   +1 more source

suPAR cut-offs for stratification of low, medium, and high-risk acute medical patients in the emergency department

BMC Emergency Medicine, 2021
Background Soluble urokinase plasminogen activator receptor (suPAR) levels have previously been associated with readmission and mortality in acute medical patients in the ED.
Seppälä Santeri, Andersen Andreas Peter, Nyyssönen Kristiina, Eugen-Olsen Jesper, Hyppölä Harri   +4 more
doaj   +1 more source

HIV-1 infected lymphoid organs upregulate expression and release of the cleaved form of uPAR that modulates chemotaxis and virus expression.

PLoS ONE, 2013
Cell-associated receptor for urokinase plasminogen activator (uPAR) is released as both full-length soluble uPAR (suPAR) and cleaved (c-suPAR) form that maintain ability to bind to integrins and other receptors, thus triggering and modulating cell ...
Manuela Nebuloni, Lidia Zawada, Angelita Ferri, Antonella Tosoni, Pietro Zerbi, Massimo Resnati, Guido Poli, Luca Genovese, Massimo Alfano   +8 more
doaj   +1 more source

Detection of soluble urokinase type plasminogen activator receptors in children with gingivitis and normal subjects

BMC Oral Health, 2022
Background Gingivitis is a reversible condition; however, if left untreated, it progresses to periodontitis, which a serious infection that leads to bone destruction.
Mohamed Abd‑Ellatif El‑Patal, Mona A. Khalil, Walaa Shipl, Ibrahim Barakat, Eman M. I. Youssef, Shahinaz El Attar, Adel Fathi, Alaa A. Abdallah   +7 more
doaj   +1 more source